Autobio offers an extensive range of IVD products, covering immunoassay, microbiology, biochemistry, and molecular diagnostics. With over 20 years of expertise, the company develops both reagents and instruments, providing fully integrated solutions tailored to the needs of medical laboratories worldwide. Notable innovations include the AutoLumo A2000 Plus (a fully automated chemiluminescence immunoassay analyzer) and the AutoMolec 3000 (an automated nucleic acid purification and real-time PCR system). This breadth and depth ensure that labs of all sizes—small, medium, or large—can rely on Autobio for cutting-edge technology that delivers accurate and efficient diagnostic results.
Autobio offers versatile immunoassay analyzers such as the AutoLumo S900, AutoLumo A6200/A6600, AutoLumo A1860, and AutoLumo A2000 Plus. These compact, advanced devices are designed to deliver test results comparable to large laboratory equipment, even from a variety of sample types, making them ideal for both clinical diagnostics and specialized medical applications.
The AutoMic-i600 from Autobio is a compact, automated microbiology analyzer for fast microbial identification and antibiotic susceptibility testing (ID-AST). With features like automatic pipetting, a 64-card incubator, and five comprehensive antibiotic cards, it delivers precise results efficiently. Enhanced by an AI-driven expert system with CLSI/EUCAST standards, dual detection methods, and full barcode management, it's ideal for modern labs.
Autobio's AutoMolec 1600 and AutoMolec 3000 are fully automated molecular diagnostic analyzers designed for efficient nucleic acid extraction and real-time PCR testing. The AutoMolec 1600 offers small-batch flexibility with results in as little as 90 minutes for DNA, while the AutoMolec 3000 supports independent testing with faster turnaround (70 minutes for DNA). Both integrate sample processing and amplification, ensuring accuracy and convenience for labs seeking reliable, high-performance molecular diagnostics.
Autobio's Ci-120x and Ci-310 are fully automated coagulation analyzers designed for precise hemostasis testing. The Ci-120x, ideal for small to medium labs, offers high-end features in a compact design, while the Ci-310 delivers a constant 300 tests/hour with advanced four-wavelength technology for medium to large labs. Both ensure accuracy, efficiency, and seamless integration, making them top choices for reliable coagulation diagnostics.
Autobio's Clinical Chemistry Analyzers, including Autolas Bi1000, Autolas Bi2600, AutoChem B861, and AutoChem B2000, deliver fast, accurate biochemical testing for labs of all sizes. The compact Autolas Bi1000 and Bi2600 suit small spaces, while the AutoChem B861 offers flexibility and the B2000 achieves up to 9600 tests/hour. These automated systems ensure reliable diagnostics, seamless integration, and efficiency, optimizing clinical chemistry workflows.
Autobio's IVD reagents cover an extensive range of diagnostics, including rheumatoid arthritis, ANCA-associated vasculitis, type 1 diabetes, respiratory infections, cardiac markers, and cancers like ovarian, lung, and colorectal. With solutions for inflammation, thyroid, diabetes, infectious diseases, and more, these high-quality IVD reagents ensure precise, reliable testing. Backed by ISO 13485 standards, Autobio's IVD reagents empower labs globally for comprehensive disease detection.
Autobio upholds rigorous quality standards, as evidenced by its ISO 13485 certification and extensive CE IVDR certifications (e.g., over 326 products certified as of September 2024). The company's focus on research and development—investing over 10% of its annual revenue—ensures that its products meet international benchmarks for safety, efficacy, and reliability. Autobio's self-sufficiency in core raw materials, such as antigens and antibodies (over 73% self-supplied), further guarantees consistent quality and supply chain stability, making it a dependable partner for labs globally.
With a network of over 800 professional service engineers in China and a presence in more than 90 countries, Autobio prioritizes customer satisfaction with timely and expert technical support. The company's "customers come first" philosophy is backed by comprehensive training, documentation, and local engineer assistance, ensuring seamless integration of its solutions into diverse laboratory settings. Events like the 9th International Distributor Forum in Dubai (February 2025) highlight Autobio's dedication to fostering strong partnerships, enhancing its reliability as a global IVD leader.
Founded in 1998 and headquartered in Zhengzhou, China, Autobio has grown into one of the world's leading in vitro diagnostics (IVD) companies, serving thousands of medical institutions across more than 90 countries. As the first IVD manufacturer listed on the Shanghai Stock Exchange's main board in 2016, Autobio combines over two decades of expertise with a relentless focus on innovation, quality, and customer satisfaction. Whether you're a small clinic seeking reliable point-of-care solutions or a large laboratory needing high-throughput diagnostics, Autobio delivers tailored, cutting-edge technology backed by a global support network. Here are the top three reasons why Autobio stands out as your trusted IVD partner.
Address: NO.87 Jingbei Yi Rd, National Eco＆Tech Zone, Zhengzhou, China
Email: info@autobio-diagnostics.com Tel: +86-371-6200-7036
Autobio Copyright Reserved for ICP 18006568. All Rights Reserved.
Select Market or Language
